Second, our previous study suggested that the symptoms of clinical depression can be ameliorated by biweekly ketamine infusion but that the inflammatory profiles of interleukin-2 and tumor necrosis factor-α may be improved more by weekly infusion (Chen,Wu et al., 2021b). The gene discussed is TNF; the disease is depressive disorder.